Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ViRap preventive treatment trial in infants with tuberous sclerosis complex
2020-003231-19Phase 2Active
- Sponsor
- Children's Memorial Health Institute
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tuberous sclerosis complex (TSC) comparing vigabatrin arm with rapamycin arm (2 arms). Started Oct 2020; status: active.
02
Drugs
vigabatrinsirolimus
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on 2020-003231-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003231-19.